Aside from PIK3CA mutation itself, there has been a suggestion [99] that mutated PIK3CA, together with other mutations that are frequently observed, such as TP53, HRAS or CDKN2A, seems to be linked to more inferior outcomes in patients with vulvar squamous cell carcinoma (VSCC). The gene discussed is PIK3CA; the disease is vulvar squamous cell carcinoma.